Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ivanhoe Aristada Drug for Schizophrenia Posted: May 18, 2024 | Last updated: May 18, 2024 More than three million people in the U.S. are living with schizophrenia. Medications can treat symptoms ...

Alkermes plc (Nasdaq: ALKS) today announced the presentation of research related to its psychiatry franchise products—LYBALVI® (olanzapine and samidorphan) and ARISTADA® (aripiprazole lauroxil)—at ...

Results from a real-world study of treatment patterns and healthcare resource utilization among patients with schizophrenia before and after initiating ARISTADA using the ARISTADA INITIO® ...

Results from a real-world study of treatment patterns and healthcare resource utilization among patients with schizophrenia before and after initiating ARISTADA using the ARISTADA INITIO ...

Results from a real-world study of treatment patterns and healthcare resource utilization among patients with schizophrenia before and after initiating ARISTADA using the ARISTADA INITIO ...

Alkermes will continue to manufacture its proprietary commercial products, VIVITROL ®, ARISTADA ®, ARISTADA INITIO ® and LYBALVI ®, at its Wilmington, Ohio manufacturing facility. About ...

Alkermes is positioned for outperformance in the pharmaceutical sector due to its conservative cash-heavy balance sheet and high-margin business model. The company focuses on therapies for alcohol ...

Kisqali (ribociclib) is a brand-name oral tablet that’s prescribed for certain types of breast cancer in adults. Kisqali has interactions with some other drugs and certain supplements. Examples ...